世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ミクロトーム市場:製品毎(器具:回転・クライオスタット、アクセサリ)、用途毎(疾病診断、医療研究)、技術毎(手動、半自動、全自動)、エンドユーザ毎(病院、臨床研究室) - 2024年までの世界市場予測

Microtome Market by Product (Instruments, (Rotary, Cryostat), Accessories), Application (Disease Diagnosis, Medical Research), Technology (Manual, Semi-automated, Fully Automated), End User (Hospital, Clinical Laboratories) - Global Forecast to 2024

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2019年8月US$5,650
シングルユーザライセンス
124 132

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)のミクロトーム市場に関する調査レポートです。

“High prevalence of cancer, growing demand for digital pathology, and increasing healthcare expenditure are expected to drive the overall growth of the microtomes market”

The microtomes market is expected to reach USD 177 million by 2024 from USD 129 million in 2019, at a CAGR of 6.5% during the forecast period. This market is experiencing significant growth due to the growing demand for digital pathology, high prevalence of cancer, and increasing healthcare expenditure. Also, the increasing focus on personalized medicine and the emerging economies are offering growth opportunities for players in the microtomes market. However, a lack of skilled professionals to operate microtomes is expected to restrain the growth of this market during the forecast period.

“Disease diagnosis is expected to dominate the market during the forecast period.”

Based on application, the microtomes market is segmented into disease diagnosis and medical research. Disease diagnosis accounted for the larger market share in 2018, as compared to other segments. Growth in the geriatric population and the increasing incidences of cancer and other chronic diseases are the factors contributing to the larger market share.

“Hospital laboratories to witness the highest growth in microtomes market, by the end-user, in 2018

Based on end-user, the microtomes market is segmented into clinical laboratories, hospital laboratories, and other end users. The hospital laboratories segment accounted for the largest market share in 2018 as well as the highest CAGR during the forecast period. The large share and the highest growth of the hospital laboratories segment are attributed to the increasing number of patient visits to hospitals, rising number of in-house clinical diagnostic procedures performed in hospitals, growing awareness regarding early diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

“North America to dominate the market during the forecast period”

Geographically, the microtomes market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2018, North America accounted for the largest share of the microtomes market. Growing opportunities for advanced cancer diagnostic testing and screening, the easy accessibility to advanced technologies, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the microtomes market in North America.

The primary interviews conducted for this report can be categorized as follows:

- By Company Type - Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
- By Designation - C-level: 33%, D-level: 40%, and Others: 27%
- By Region - North America: 36%, Europe: 28%, Asia Pacific: 19%, Rest of the World: 17%

List of Companies Profiled in the Report

- Thermo Fisher Scientific (US)
- Danaher Corporation (US)
- Diapath S.P.A.
- Sakura Finetek (Japan)
- SLEE Medical GmbH (Germany)
- MEDITE GmbH (Germany)
- Histo-Line Laboratories (Italy)
- Amos Scientific (Australia)
- RMC Boeckeler, Diapath S.p.A. (Italy)
- Jinhua YIDI Medical Appliance (China)

Research Coverage:

This report provides a detailed picture of the global microtomes market. It aims at estimating the size and future growth potential of the market across different segments, such as product, technology, application, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall microtomes market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.



目次

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 17
1.5 LIMITATION 17
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 18
2.1.1.1 Secondary source 19
2.1.2 PRIMARY DATA 19
2.1.2.1 Key data from primary sources 20
2.2 MARKET SIZE ESTIMATION 21
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.4 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 MICROTOMES: MARKET OVERVIEW 28
4.2 ASIA PACIFIC: MICROTOMES MARKET SHARE, BY END USER AND COUNTRY (2019) 29
4.3 MICROTOMES MARKET, BY TECHNOLOGY (USD MILLION) 30
4.4 MICROTOMES MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 30
4.5 MICROTOMES MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION) 31
4.6 GEOGRAPHICAL SNAPSHOT OF THE MICROTOMES MARKET 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 32
5.2 MARKET DYNAMICS 32
5.2.1 MARKET DRIVERS 32
5.2.1.1 High prevalence of cancer 32
5.2.1.2 Growing demand for digital pathology 33
5.2.1.3 Increasing healthcare expenditure 34
-
5.2.2 MARKET RESTRAINTS 35
5.2.2.1 Lack of skilled professionals 35
5.2.3 MARKET OPPORTUNITIES 35
5.2.3.1 Growing focus on personalized medicine 35
5.2.3.2 Emerging economies 36
6 MICROTOMES MARKET, BY PRODUCT 37
6.1 INTRODUCTION 38
6.2 MICROTOME INSTRUMENTS 39
6.2.1 ROTARY MICROTOMES 40
6.2.1.1 Rotary microtomes are the most common types of microtomes used in histology laboratories 40
6.2.2 CRYOSTAT MICROTOMES 41
6.2.2.1 Cryostat microtomes provide immediate results by quickly, reliably, and safely cutting accurate frozen sections 41
6.2.3 VIBRATING MICROTOMES 41
6.2.3.1 Vibrating microtomes are designed to cut fresh tissue specimens 41
6.2.4 OTHER MICROTOMES 42
6.3 MICROTOME ACCESSORIES 43
6.3.1 THE ADOPTION OF DISPOSABLE BLADES HAS INCREASED AS THEY HELP IN PRODUCING HIGH-QUALITY SECTIONS 43
7 MICROTOMES MARKET, BY APPLICATION 45
7.1 INTRODUCTION 46
7.2 DISEASE DIAGNOSIS 47
7.2.1 HIGH PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 47
7.3 MEDICAL RESEARCH 47
7.3.1 INCREASING RESEARCH ACTIVITIES TO DRIVE THE ADOPTION OF MICROTOMES 47
8 MICROTOMES MARKET, BY TECHNOLOGY 49
8.1 INTRODUCTION 50
8.2 MANUAL MICROTOMES 51
8.2.1 LOWER COST AND USER COMFORT ASSOCIATED WITH THESE MICROTOMES ARE DRIVING THEIR ADOPTION 51
8.3 SEMI-AUTOMATED MICROTOMES 52
8.3.1 SEMI-AUTOMATED MICROTOMES TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 52
8.4 FULLY AUTOMATED MICROTOMES 53
8.4.1 LACK OF CLINICAL LABORATORY TECHNICIANS AND THE HIGH PREVALENCE OF CANCER HAVE RESULTED IN THE INCREASED ADOPTION OF FULLY AUTOMATED MICROTOMES 53
-
9 MICROTOMES MARKET, BY END USER 54
9.1 INTRODUCTION 55
9.2 HOSPITAL LABORATORIES 56
9.2.1 HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF
THE MARKET, BY END USER 56
9.3 CLINICAL LABORATORIES 57
9.3.1 PRESENCE OF ROBUST INFRASTRUCTURE TO PERFORM TESTS IN HIGH VOLUMES IS ESTIMATED TO DRIVE MARKET GROWTH 57
9.4 OTHER END USERS 57
10 MICROTOMES MARKET, BY REGION 59
10.1 INTRODUCTION 60
10.2 NORTH AMERICA 61
10.2.1 US 64
10.2.1.1 High burden of cancer and numerous conferences on anatomic pathology to drive market growth 64
10.2.2 CANADA 67
10.2.2.1 Availability of research funding & rising incidence of cancer to drive market growth 67
10.3 EUROPE 70
10.3.1 GERMANY 73
10.3.1.1 Increasing prevalence of chronic diseases and large-scale outsourcing of clinical diagnostic tests by hospitals to commercial service providers to support market growth 73
10.3.2 UK 74
10.3.2.1 Government initiatives to drive market growth in the UK 74
10.3.3 FRANCE 76
10.3.3.1 High prevalence of cancer to support market growth in France 76
10.3.4 ITALY 78
10.3.4.1 High prevalence of cancer and increasing per capita healthcare spending to support market growth in Italy 78
10.3.5 SPAIN 79
10.3.5.1 High incidence of chronic diseases to drive market growth in Spain 79
10.3.6 REST OF EUROPE 81
10.4 ASIA PACIFIC 83
10.4.1 JAPAN 86
10.4.1.1 Presence of a well-developed healthcare system to support market growth in Japan 86
10.4.2 CHINA 87
10.4.2.1 Rising healthcare expenditure to drive the market growth 87
10.4.3 INDIA 89
10.4.3.1 Growing healthcare sector in the country to drive market growth 89
10.4.4 REST OF ASIA PACIFIC 91
10.5 REST OF THE WORLD 92
11 COMPETITIVE LANDSCAPE 96
11.1 OVERVIEW 96
11.2 MARKET SHARE ANALYSIS, 2018 97
11.3 COMPETITIVE SCENARIO 98
11.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016-2019) 98
11.3.2 PRODUCT LAUNCHES (2016-2019) 98
11.3.3 ACQUISITIONS (2016-2019) 99
11.4 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) 99
11.4.1 VENDOR INCLUSION CRITERIA 99
11.4.2 VANGUARDS 99
11.4.3 INNOVATORS 99
11.4.4 DYNAMIC PLAYERS 99
11.4.5 EMERGING PLAYERS 100
12 COMPANY PROFILES 101
(Business overview, Products offered, Recent developments, MNM view)*
12.1 AMOS SCIENTIFIC PTY LTD 101
12.2 DANAHER 102
12.3 DIAPATH S.P.A. 104
12.4 HISTO-LINE LABORATORIES 105
12.5 JINHUA YIDI MEDICAL APPLIANCE CO.,LTD 106
12.6 MEDITE GMBH 108
12.7 RMC BOECKELER 109
12.8 SAKURA FINETEK 110
12.9 SLEE MEDICAL GMBH 112
12.10 THERMO FISHER SCIENTIFIC 113
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX 116
13.1 INSIGHTS FROM INDUSTRY EXPERTS 116
13.2 DISCUSSION GUIDE 117
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 120
13.4 AVAILABLE CUSTOMIZATION 122
13.5 RELATED REPORTS 122
13.6 AUTHOR DETAILS 123

 

LIST OF TABLES

TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 33
TABLE 2 HEALTHCARE SPENDING (% OF GDP), BY COUNTRY, 2006 VS. 2016 34
TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008-2016 35
TABLE 4 MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 38
TABLE 5 MICROTOME INSTRUMENTS MARKET, BY REGION, 2017-2024 (USD MILLION) 39
TABLE 6 MICROTOME INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION) 39
TABLE 7 ROTARY MICROTOMES MARKET, BY REGION, 2017-2024 (USD MILLION) 40
TABLE 8 CRYOSTAT MICROTOMES MARKET, BY REGION, 2017-2024 (USD MILLION) 41
TABLE 9 VIBRATING MICROTOMES MARKET, BY REGION, 2017-2024 (USD MILLION) 42
TABLE 10 OTHER MICROTOMES MARKET, BY REGION, 2017-2024 (USD MILLION) 43
TABLE 11 MICROTOME ACCESSORIES MARKET, BY REGION, 2017-2024 (USD MILLION) 44
TABLE 12 MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 46
TABLE 13 MICROTOMES MARKET FOR DISEASE DIAGNOSIS, BY REGION,
2017-2024 (USD MILLION) 47
TABLE 14 MICROTOMES MARKET FOR MEDICAL RESEARCH, BY REGION,
2017-2024 (USD MILLION) 48
TABLE 15 MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 50
TABLE 16 MANUAL MICROTOMES MARKET, BY REGION, 2017-2024 (USD MILLION) 51
TABLE 17 SEMI-AUTOMATED MICROTOMES MARKET, BY REGION,
2017-2024 (USD MILLION) 52
TABLE 18 FULLY AUTOMATED MICROTOMES MARKET, BY REGION,
2017-2024 (USD MILLION) 53
TABLE 19 MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 55
TABLE 20 MICROTOMES MARKET FOR HOSPITAL LABORATORIES, BY REGION,
2017-2024 (USD MILLION) 56
TABLE 21 MICROTOMES MARKET FOR CLINICAL LABORATORIES, BY REGION,
2017-2024 (USD MILLION) 57
TABLE 22 MICROTOMES MARKET FOR OTHER END USERS, BY REGION,
2017-2024 (USD MILLION) 58
TABLE 23 MICROTOMES MARKET, BY REGION, 2017-2024 (USD MILLION) 60
TABLE 24 NORTH AMERICA: MICROTOMES MARKET, BY COUNTRY,
2017-2024 (USD MILLION) 62
TABLE 25 NORTH AMERICA: MICROTOMES MARKET, BY PRODUCT,
2017-2024 (USD MILLION) 62
TABLE 26 NORTH AMERICA: MICROTOME INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 62
TABLE 27 NORTH AMERICA: MICROTOMES MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 63
TABLE 28 NORTH AMERICA: MICROTOMES MARKET, BY TECHNOLOGY,
2017-2024 (USD MILLION) 63
TABLE 29 NORTH AMERICA: MICROTOMES MARKET, BY END USER,
2017-2024 (USD MILLION) 63
TABLE 30 CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US 64
TABLE 31 US: KEY MACROINDICATORS 65
TABLE 32 US: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 65
TABLE 33 US: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 66
TABLE 34 US: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 66
TABLE 35 US: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 66
TABLE 36 CANADA: KEY MACROINDICATORS 67
TABLE 37 CANADA: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 68
TABLE 38 CANADA: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 68
TABLE 39 CANADA: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 68
TABLE 40 CANADA: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 69
TABLE 41 EUROPE: MICROTOMES MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 71
TABLE 42 EUROPE: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 71
TABLE 43 EUROPE: MICROTOME INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 71
TABLE 44 EUROPE: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 72
TABLE 45 EUROPE: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 72
TABLE 46 EUROPE: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 72
TABLE 47 GERMANY: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 73
TABLE 48 GERMANY: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 73
TABLE 49 GERMANY: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 74
TABLE 50 GERMANY: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 74
TABLE 51 UK: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 75
TABLE 52 UK: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 75
TABLE 53 UK: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 75
TABLE 54 UK: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 76
TABLE 55 FRANCE: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 76
TABLE 56 FRANCE: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 77
TABLE 57 FRANCE: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 77
TABLE 58 FRANCE: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 77
TABLE 59 ITALY: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 78
TABLE 60 ITALY: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 78
TABLE 61 ITALY: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 79
TABLE 62 ITALY: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 79
TABLE 63 SPAIN: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 80
TABLE 64 SPAIN: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 80
TABLE 65 SPAIN: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 80
TABLE 66 SPAIN: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 81
TABLE 67 ROE: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 81
TABLE 68 ROE: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 82
TABLE 69 ROE: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 82
TABLE 70 ROE: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 82
TABLE 71 ASIA PACIFIC: MICROTOMES MARKET, BY COUNTRY, 2017-2024 (USD MILLION) 84
TABLE 72 ASIA PACIFIC: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 84
TABLE 73 ASIA PACIFIC: MICROTOME INSTRUMENTS MARKET, BY TYPE,
2017-2024 (USD MILLION) 84
TABLE 74 ASIA PACIFIC: MICROTOMES MARKET, BY APPLICATION,
2017-2024 (USD MILLION) 85
TABLE 75 ASIA PACIFIC: MICROTOMES MARKET, BY TECHNOLOGY,
2017-2024 (USD MILLION) 85
TABLE 76 ASIA PACIFIC: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 85
TABLE 77 JAPAN: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 86
TABLE 78 JAPAN: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 86
TABLE 79 JAPAN: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 87
TABLE 80 JAPAN: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 87
TABLE 81 CHINA: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 88
TABLE 82 CHINA: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 88
TABLE 83 CHINA: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 88
TABLE 84 CHINA: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 89
TABLE 85 INDIA: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 89
TABLE 86 INDIA: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 90
TABLE 87 INDIA: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 90
TABLE 88 INDIA: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 90
TABLE 89 ROAPAC: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 91
TABLE 90 ROAPAC: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 91
TABLE 91 ROAPAC: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 92
TABLE 92 ROAPAC: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 92
TABLE 93 ROW: MICROTOMES MARKET, BY PRODUCT, 2017-2024 (USD MILLION) 93
TABLE 94 ROW: MICROTOME INSTRUMENTS MARKET, BY TYPE, 2017-2024 (USD MILLION) 94
TABLE 95 ROW: MICROTOMES MARKET, BY APPLICATION, 2017-2024 (USD MILLION) 94
TABLE 96 ROW: MICROTOMES MARKET, BY TECHNOLOGY, 2017-2024 (USD MILLION) 95
TABLE 97 ROW: MICROTOMES MARKET, BY END USER, 2017-2024 (USD MILLION) 95

 

LIST OF FIGURES

FIGURE 1 MICROTOMES MARKET SEGMENTS 16
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 20
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 21
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 21
FIGURE 6 DATA TRIANGULATION METHODOLOGY 22
FIGURE 7 MICROTOMES MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION) 24
FIGURE 8 MICROTOME INSTRUMENTS MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 25
FIGURE 9 MICROTOMES MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION) 25
FIGURE 10 MICROTOMES MARKET, BY TECHNOLOGY (USD MILLION) 26
FIGURE 11 MICROTOMES MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 26
FIGURE 12 GEOGRAPHICAL SNAPSHOT: MICROTOMES MARKET 27
FIGURE 13 MICROTOMES MARKET TO WITNESS SINGLE-DIGIT GROWTH RATE DURING
THE FORECAST PERIOD 28
FIGURE 14 HOSPITAL LABORATORIES TO COMMAND THE LARGEST SHARE OF THE APAC MICROTOMES MARKET IN 2019 29
FIGURE 15 SEMI-AUTOMATED MICROTOMES TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 30
FIGURE 16 DISEASE DIAGNOSIS SEGMENT IS PROJECTED TO DOMINATE THE MICROTOMES MARKET IN 2024 30
FIGURE 17 MICROTOME INSTRUMENTS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 31
FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 31
FIGURE 19 MICROTOMES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 32
FIGURE 20 MICROTOME ACCESSORIES TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 38
FIGURE 21 DISEASE DIAGNOSIS SEGMENT WILL CONTINUE TO DOMINATE THE MICROTOMES MARKET DURING THE FORECAST PERIOD 46
FIGURE 22 MANUAL MICROTOMES SEGMENT WILL CONTINUE TO DOMINATE
THE MICROTOMES MARKET IN 2024 50
FIGURE 23 HOSPITAL LABORATORIES SEGMENT TO DOMINATE THE MICROTOMES MARKET DURING THE FORECAST PERIOD 55
FIGURE 24 NORTH AMERICA: MICROTOMES MARKET SNAPSHOT 61
FIGURE 25 US: CANCER STATISTICS 64
FIGURE 26 CANADA: CANCER STATISTICS 67
FIGURE 27 EUROPE: MICROTOMES MARKET SNAPSHOT 70
FIGURE 28 ASIA PACIFIC: MICROTOMES MARKET SNAPSHOT 83
FIGURE 29 ROW: MICROTOMES MARKET SNAPSHOT 93
FIGURE 30 KEY DEVELOPMENTS IN THE MICROTOMES MARKET BETWEEN 2016 AND 2019 96
FIGURE 31 MARKET EVOLUTION FRAMEWORK 97
FIGURE 32 MICROTOMES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 97
FIGURE 33 MICROTOMES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019 100
FIGURE 34 COMPANY SNAPSHOT: DANAHER 102
FIGURE 35 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC 113

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る